NCT07746531ClinicalTrials.gov
Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System
In brief
The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign…
Observational112 participants sought2 sites1 country
Registered in 1 registry
- ClinicalTrials.govNCT07746531Open this record at ClinicalTrials.govSynced 2 days ago
One study can be registered in several registries. We show it once and link every record we hold.
Trial information is shown as published by the registry, in its original language.
Interested in this study?
Sign in or create an account to register your interest and follow this study.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-08-05; recorded start 2026-08-20
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: Whether there is a comparison group is not stated in the registry recordThe record does not describe the study arms
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 5 other studies in this databaseCounted from the lead sponsor named in the record (Distalmotion SA)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A small study: 112 participants (target), run at 2 sites.
How this score is built
- Enrolment19/40
112 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 28 months
- Sponsor scale2/10
Distalmotion SA has led 6 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Summary
The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.
Conditions
- Hysterectomy, Benign Uterine Diseases
Eligibility
| Sex | Female |
|---|---|
| Ages | 22 Years – No maximum |
| Healthy volunteers | No |
| Sampling method | NON_PROBABILITY_SAMPLE |
Study population
Adult patients undergoing a hysterectomy for benign disease
Eligibility as written in the registry
Eligibility in plain statements
This record's criteria have not been broken into separate statements yet. The registry text above is complete and is the authoritative version.
Study design
| Study type | Observational |
|---|---|
| Phase | Not stated in the registry record |
| Allocation | Not stated in the registry record |
| Intervention model | Not stated in the registry record |
| Primary purpose | Not stated in the registry record |
| Masking | Not stated in the registry record |
| Enrolment | 112 participants sought |
Sponsor and collaborators
- Distalmotion SA Sponsor
Interventions
- Device benign hysterectomy
Robotic-assisted and laparoscopic hysterectomy for benign disease with the DEXTER robotic surgery system.
Outcome measures
Primary outcome
Primary safety outcome
Occurrence of Clavien-Dindo grades III-V adverse events
Time frame up to 42 days after surgery
Primary outcome
Primary efficacy outcome
Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
Time frame Intraoperative
Dates
| Start date | August 20, 2026 (actual) |
|---|---|
| Primary completion | December 1, 2028 (estimated) |
| Completion | December 1, 2028 (estimated) |
| First posted | August 5, 2026 (actual) |
| Last updated | November 17, 2026 |
| Results posted | Not stated in the registry record |
| Status last verified | November 2026 |
Actual means the event happened. Estimated means the sponsor expects it. The two mean different things.
Locations
1 site is recruiting
United States
| Facility | City | State or region | Status |
|---|---|---|---|
| Memorial Hermann-Texas Medical Center - UT Health Houston | Houston | Texas | Not yet recruiting |
| Cypress surgery center | Wichita | Kansas | Recruiting |
Study documents
No documents are linked in this registry record.
Changes over time
- November 17, 2026
Status changed
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- November 17, 2026
Recruitment opened
Recruitment opened
NOT_YET_RECRUITINGRECRUITING